PRICE AND YTD RETURN As of 02/12/2016

NAV up $0.69 $40.98
POP $43.48
YTD Total return at Nav -16.14%

AVERAGE ANNUAL TOTAL RETURNS As of Quarter end 12/31/2015

Sales Charge

1 YEAR RETURN 2.24%
5 YEAR RETURN 11.50%
10 YEAR RETURN 8.39%

KEY STATS

Investment Category Growth
Distributions Annually
CUSIP 353 496 201
Fund Number 108
Inception Date Jan 01, 1968
Total Net Assets (all share classes) As of 01/31/2016 $2,847.2 (M)
Distribution Rate at NAV N/A
30-Day Standardized yield N/A

SALES CHARGE, EXPENSES, & FEES As of 02/01/2016 (updated annually)

Gross Expense Ratio 0.89%
Net Expense Ratio 0.89%
Max Initial Sales Charge 5.75%
CDSC 0.00%
12b-1 Fee 0.25%

Fund Description

The fund seeks capital appreciation by investing primarily in companies which management believes are leaders in innovation, take advantage of new technologies, have superior management, and benefit from new industry conditions in the dynamically changing global economy.

Strategy Statement

"We focus on companies that are leaders in innovation, take advantage of new technologies, have superior management, and benefit from new industry conditions."

Management

Matthew Moberg, MBA

Matthew Moberg, MBA

  • Joined Franklin Templeton in 1998
  • Managed Fund Since 2004
Rupert Johnson Jr.

Rupert Johnson Jr.

  • Joined Franklin Templeton in 1965
  • Managed Fund Since 1968

Overall Morningstar Rating As of 01/31/2016

Rating Category: Large Growth

Morningstar
The fund's overall Morningstar Rating measures risk-adjusted returns and is derived from a weighted average of the performance figures associated with its 3-, 5- and 10-year (if applicable) rating metrics.

Historical Morningstar Rating As of 01/31/2016

Years Ratings Funds
in category
3
2 Stars
1546
5
2 Stars
1325
10
3 Stars
936

Morningstar Style Box As of 12/31/2015

Strategy, Benefits, Results

Strategy

We use fundamental, bottom-up research to find innovative, fast-growing companies that meet our criteria of

  • Growth. We focus on companies with the potential to produce sustainable earnings and cash-flow growth.
  • Quality. We seek high-quality companies with strong management teams and financial strength.
  • Valuation. We assess whether the growth opportunity is already reflected in the stock price.

Benefits

  • Participate in trends moving markets. Invest in innovative sectors—technology, medicine, global communications—that we believe are poised for long-term growth.
  • Tenured and experienced. Portfolio management team has a combined 56 years of industry experience.
  • Distinct research structure. Our investment professionals are organized into collaborative sector teams.

Investing In The Fund

What Are the Risks?
  • All investments involve risks, including possible loss of principal.
  • Stocks historically have outperformed other asset classes over the long term, but tend to fluctuate more dramatically over the short term.
  • Investments in fast-growing industries like the technology and healthcare sectors (which have historically been volatile) could result in increased price fluctuation, especially over the short term, due to the rapid pace of product change and development and changes in government regulation of companies emphasizing scientific or technological advancement or regulatory approval for new drugs and medical instruments.
  • The fund may also invest in small- and mid-capitalization companies, which can be particularly sensitive to changing economic conditions, and their prospects for growth are less certain than those of larger, more established companies.
  • These and other risks are described more fully in the fund’s prospectus.

Minimum Investment

$1,000.00

How Financial Advisors Help You

Speak to your financial advisor about whether this fund is appropriate for you. If you don't have a financial advisor, request a referral.

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.